William Blair Downgrades VNUS Medical (VNUS) to Market Perform
More News related to VNUS
- Roth Capital Downgrades VNUS Medical Technologies (VNUS) to Hold
- William Blair Downgrades VNUS Medical (VNUS) to Market Perform
- Notable Mergers and Acquisitions of the Day 5/8: COV/VNUS
- Morning Movers 5/8: FTWR, RDNT, VNUS, AXL, FITB, LEAP Higher; DPTR, CROX, INAP, HUN, GNW Lower
- Covidien (COV) To Acquire VNUS Medical (VNUS) For $29/Share
More News related to Downgrades
- Hydrogenics Resumes Trading Under NASDAQ Symbol "HYGS"
- Varian Medical (VAR) to Highlight its New Range of Detectors at Annual RSNA Meeting in Chicago
- Manulife (MFC) Confirms No Exposure to Dubai World
- Activision's (ATVI) Call of Duty Amasses $3 Billion in Global Sales
- Seiko Epson to Transfer Sales Function of Small and Medium-Sized TFT LCD Business to Sony (SNE)
William Blair downgrades VNUS Medical (Nasdaq: VNUS) from Outperform to Market Perform.
VNUS Medical Technologies, Inc. develops, manufactures and licenses products used in the minimally invasive treatment of venous reflux disease, including disposable endovenous catheters and radio-frequency (RF) generators.
To see more analyst ratings on VNUS Click Here.
Related Categories
DowngradesStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
